AMPH vs DFS
Amphastar P (AMPH) versus DFS (DFS) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
DFS (DFS) common stock.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
DFS does not have a complete income-statement cache yet.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Not investment advice. Open the AMPH and DFS stock pages for the full models.
Not investment advice.